Modulation of macrophage fatty acid content and composition by exposure to dyslipidemic serum in vitro

Lipids

Volumn 46, Issue 4, 2011, Pages 371-380

  Wong, Bruce X W ^a   Kyle, Reece A ^a   Croft, Kevin D ^a   Quinn, Carmel M ^b   Jessup, Wendy ^b   Yeap, Bu B ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c FREMANTLE HOSPITAL   (Australia)

Author keywords

Atherogenesis; Dyslipidemia; Fatty acids; Macrophage; Triglyceride; Unsaturated fatty acids

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ACTIN; ACYL COENZYME A DESATURASE; CHOLESTEROL; CLUSTER OF DIFFERENTIATION 36; FATTY ACID; FRESH FROZEN PLASMA; HIGH DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER RECEPTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; CHOLESTEROL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DYSLIPIDEMIA; FATTY ACID ANALYSIS; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; LIPID COMPOSITION; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; MACROPHAGE; MONOCYTE; PROTEIN EXPRESSION;

ANTIGENS, CD36; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CULTURE MEDIA; DYSLIPIDEMIAS; FATTY ACIDS; HUMANS; MACROPHAGES; SERUM; STEAROYL-COA DESATURASE; TRIGLYCERIDES;

EID: 79956012319     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-011-3528-2     Document Type: Article

References (37)

1. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D (2004) European guidelines on cardiovascular disease prevention in clinical practice. Atherosclerosis 173:381-391
2. Manning-Tobin JJ, Moore KJ, Seimon TA, Bell SA, Sharuk M, Alvarez-Leite JI, de Winther MP, Tabas I, Freeman MW (2009) Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol 29:19-26
3. Baillie AG, Coburn CT, Abumrad NA (1996) Reversible binding of long-chain fatty acids to purified FAT, the adipose CD36 homolog. J Membr Biol 153:75-81
4. Jessup W, Gelissen IC, Gaus K, Kritharides L (2006) Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr Opin Lipidol 17:247-257
5. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, Lowe GD (1999) Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 30:841-850
6. Jacobson TA, Miller M, Schaefer EJ (2007) Hypertriglyceridemia and cardiovascular risk reduction. Clin Ther 29:763-777
7. Assmann A, Mohlig M, Osterhoff M, Pfeiffer AF, Spranger J (2008) Fatty acids differentially modify the expression of urokinase type plasminogen activator receptor in monocytes. Biochem Biophys Res Commun 376:196-199
8. Baird SK, Reid L, Hampton MB, Gieseg SP (2005) OxLDL induced cell death is inhibited by the macrophage synthesised pterin, 7,8-dihydroneopterin, in U937 cells but not THP-1 cells. Biochim Biophys Acta 1745:361-369
9. Gleissner CA, Sanders JM, Nadler J, Ley K (2008) Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis. Arterioscler Thromb Vasc Biol 28:1137-1143
10. Sarov-Blat L, Kiss RS, Haidar B, Kavaslar N, Jaye M, Bertiaux M, Steplewski K, Hurle MR, Sprecher D, McPherson R, Marcel YL (2007) Predominance of a proinflammatory phenotype in monocyte-derived macrophages from subjects with low plasma HDL-cholesterol. Arterioscler Thromb Vasc Biol 27:1115-1122
11. Senanayake S, Brownrigg LM, Panicker V, Croft KD, Joyce DA, Steer JH, Puddey IB, Yeap BB (2007) Monocyte-derived macrophages from men and women with type 2 diabetes mellitus differ in fatty acid composition compared with non-diabetic controls. Diabetes Res Clin Pract 75:292-300
12. Attie AD, Krauss RM, Gray-Keller MP, Brownlie A, Miyazaki M, Kastelein JJ, Lusis AJ, Stalenhoef AF, Stoehr JP, Hayden MR, Ntambi JM (2002) Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 43:1899-1907
13. Rifai N, Warnick GR (2006) Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE (eds) Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th edn. Elsevier Saunders, St Louis, pp 903-981
14. Botham KM, Moore EH, De Pascale C, Bejta F (2007) The induction of macrophage foam cell formation by chylomicron remnants. Biochem Soc Trans 35:454-458
15. Batt KV, Patel L, Botham KM, Suckling KE (2004) Chylomicron remnants and oxidised low density lipoprotein have differential effects on the expression of mRNA for genes involved in human macrophage foam cell formation. J Mol Med 82:449-458
16. De Pascale C, Avella M, Perona JS, Ruiz-Gutierrez V, Wheeler-Jones CP, Botham KM (2006) Fatty acid composition of chylomicron remnant-like particles influences their uptake and induction of lipid accumulation in macrophages. FEBS J 273:5632-5640
17. Moore EH, Bejta F, Avella M, Suckling KE, Botham KM (2005) Efflux of lipid from macrophages after induction of lipid accumulation by chylomicron remnants. Biochim Biophys Acta 1735:20-29
18. Legrand P, Rioux V (2010) The complex and important cellular and metabolic functions of saturated fatty acids. Lipids 45:941-946
19. Wang Y, Kurdi-Haidar B, Oram JF (2004) LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1. J Lipid Res 45:972-980
20. Wang Y, Oram JF (2007) Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway. J Lipid Res 48:1062-1068
21. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Gugiu B, Fox PL, Hoff HF, Salomon RG, Hazen SL (2002) Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem 277:38503-38516
22. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93:241-252
23. Yesner LM, Huh HY, Pearce SF, Silverstein RL (1996) Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol 16:1019-1025
24. Han J, Hajjar DP, Febbraio M, Nicholson AC (1997) Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem 272:21654-21659
25. Vallve JC, Uliaque K, Girona J, Cabre A, Ribalta J, Heras M, Masana L (2002) Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages. Atherosclerosis 164:45-56
26. Han J, Hajjar DP, Tauras JM, Nicholson AC (1999) Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36. J Lipid Res 40:830-838
27. Nakagawa T, Nozaki S, Nishida M, Yakub JM, Tomiyama Y, Nakata A, Matsumoto K, Funahashi T, Kameda-Takemura K, Kurata Y, Yamashita S, Matsuzawa Y (1998) Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 18:1350-1357
28. Han J, Hajjar DP, Tauras JM, Feng J, Gotto AM Jr, Nicholson AC (2000) Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J Biol Chem 275:1241-1246
29. Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S, Rhee JS, Silverstein R, Hoff HF, Freeman MW (2002) Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 277:49982-49988
30. Ntambi JM, Miyazaki M (2003) Recent insights into stearoyl-CoA desaturase-1. Curr Opin Lipidol 14:255-261
31. Graham A, Zammit VA, Brindley DN (1998) Fatty acid specificity for the synthesis of triacylglycerol and phosphatidylcholine and for the secretion of very-low-density lipoproteins and lysophosphatidylcholine by cultures of rat hepatocytes. Biochem J 249:727-733
32. de Lima-Salgado TM, Alba-Loureiro TC, do Nascimento CS, Nunes MT, Cuir R (2010) Molecular mechanisms by which saturated fatty acids modulate TNF-a expression in mouse macrophage lineage. Cell Biochem Biophys doi:10.1007/s12013-010-9117-9
33. Sankaranarayanan S, de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Weibel GL, Rothblat GH (2010) Importance of macrophage cholesterol content on the flux of cholesterol mass. J Lipid Res 51:3243-3249
34. Xu M, Zhou H, Tan KCB, Guo R, Shiu SWM, Wong Y (2009) ABCG1 mediated oxidised LDL-derived oxysterol efflux from macrophages. Biochm Biophys Res Commun 390:1349-1354
35. Mooradian AD (2009) Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 5:150-159
36. Paramsothy P, Knopp RH, Bertoni AG, Blumenthal RS, Wasserman BA, Tsai MY, Rue T, Wong ND, Heckbert SR (2010) Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 56:1034-1041
37. Lagos KG, Filippatos TD, Tsimihodimos V, Gazi IF, Rizos C, Tselepis AD, Mikhailidis DP, Elisaf MS (2009) Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome. Lipids 44:9-16